Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Postoperative Human Papilloma Virus Circulating Tumor DNA Guided Adjuvant Therapy for Human Papilloma Virus-Related Oropharyngeal Carcinoma (PATH Study).

The PATH study used the NavDx tumor-tissue-modified viral HPV DNA score after surgery to select people with HPV-positive oropharyngeal cancer for omission or delay of adjuvant radiation.

International Journal of Radiation Oncology, Biology, PhysicsPubMed 41043558DOI 10.1016/j.ijrobp.2025.09.044